Skip Navigation


QJM Advance Access originally published online on May 6, 2005
QJM 2005 98(6):451-456; doi:10.1093/qjmed/hci073
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
98/6/451    most recent
hci073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baughman, R.P.
Right arrow Articles by Lower, E.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baughman, R.P.
Right arrow Articles by Lower, E.E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Fungal infections as a complication of therapy for sarcoidosis

R.P. Baughman and E.E. Lower

From the Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, USA

Address correspondence to Dr R.P. Baughman, 1001 Holmes, Eden Ave, Cincinnati, OH 45267–0565, USA. e-mail: bob.baughman{at}uc.edu

Received 13 February 2005 and in revised form 12 March 2005

Background: Treatment of symptomatic sarcoidosis usually includes systemic immunosuppressive agents. These agents may render the patient more susceptible to opportunistic infections. In addition, the fungal infection may be difficult to distinguish from the underlying sarcoidosis.

Aim: To examine the presentation and management of invasive fungal infections in sarcoidosis patients.

Design: Retrospective record review.

Methods: We reviewed the notes of all sarcoidosis patients (n = 753) seen at our clinic over an 18-month period.

Results: Seven patients (0.9%) with previously diagnosed sarcoidosis developed fungal infections: two each with Histoplasma capsulatum and Blastomyces dermatitidis and three others with Cryptococcus neoformans. No cases of invasive aspergillus or tuberculosis were identified. The diagnosis of fungal infection was made by bronchoscopy (four cases), open-lung biopsy (one case), bone-marrow aspirate (one case), and spinal fluid examination (one case). All patients were receiving corticosteroids at the time of worsening chest X-ray or clinical status. Four patients were also receiving methotrexate prior to infection. No patient with systemic fungal infection was receiving either infliximab or cyclophosphamide. All patients responded to anti-fungal therapy and a reduction in immunosuppression.

Discussion: Fungal infections occur rarely in treated patients with sarcoidosis. Deterioration of chest X-ray, especially a localized infiltrate, warrants investigation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
R. P. Baughman, M. Drent, M. Kavuru, M. A. Judson, U. Costabel, R. du Bois, C. Albera, M. Brutsche, G. Davis, J. F. Donohue, et al.
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 795 - 802.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.